These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36822200)

  • 1. DNA-initiated epigenetic cascades driven by C9orf72 hexanucleotide repeat.
    Liu Y; Huang Z; Liu H; Ji Z; Arora A; Cai D; Wang H; Liu M; Simko EAJ; Zhang Y; Periz G; Liu Z; Wang J
    Neuron; 2023 Apr; 111(8):1205-1221.e9. PubMed ID: 36822200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
    Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
    Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
    Beckers J; Tharkeshwar AK; Van Damme P
    Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DAXX tax: C9orf72 DNA repeat expansions drive gain- and loss-of-function pathology in c9FTD/ALS.
    Liu F; Rossoll W
    Neuron; 2023 Apr; 111(8):1165-1167. PubMed ID: 37080165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD.
    Coyne AN; Rothstein JD
    Acta Neuropathol Commun; 2021 Mar; 9(1):45. PubMed ID: 33741069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
    Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
    Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic disease modifiers in an Italian
    Ratti A; Peverelli S; D'Adda E; Colombrita C; Gennuso M; Prelle A; Silani V
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):292-298. PubMed ID: 34382491
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiogenomics of
    Bonham LW; Geier EG; Sirkis DW; Leong JK; Ramos EM; Wang Q; Karydas A; Lee SE; Sturm VE; Sawyer RP; Friedberg A; Ichida JK; Gitler AD; Sugrue L; Cordingley M; Bee W; Weber E; Kramer JH; Rankin KP; Rosen HJ; Boxer AL; Seeley WW; Ravits J; Miller BL; Yokoyama JS
    J Neurosci; 2023 Jan; 43(2):333-345. PubMed ID: 36446586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
    Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
    Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.
    Meijboom KE; Abdallah A; Fordham NP; Nagase H; Rodriguez T; Kraus C; Gendron TF; Krishnan G; Esanov R; Andrade NS; Rybin MJ; Ramic M; Stephens ZD; Edraki A; Blackwood MT; Kahriman A; Henninger N; Kocher JA; Benatar M; Brodsky MH; Petrucelli L; Gao FB; Sontheimer EJ; Brown RH; Zeier Z; Mueller C
    Nat Commun; 2022 Oct; 13(1):6286. PubMed ID: 36271076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
    Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
    Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
    Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
    Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
    Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
    Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry.
    Mesaros M; Lenz S; Lim W; Brown J; Drury L; Roggenbuck J
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?
    Sellier C; Corcia P; Vourc'h P; Dupuis L
    Rev Neurol (Paris); 2024 May; 180(5):417-428. PubMed ID: 38609750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.
    Shi Y; Lin S; Staats KA; Li Y; Chang WH; Hung ST; Hendricks E; Linares GR; Wang Y; Son EY; Wen X; Kisler K; Wilkinson B; Menendez L; Sugawara T; Woolwine P; Huang M; Cowan MJ; Ge B; Koutsodendris N; Sandor KP; Komberg J; Vangoor VR; Senthilkumar K; Hennes V; Seah C; Nelson AR; Cheng TY; Lee SJ; August PR; Chen JA; Wisniewski N; Hanson-Smith V; Belgard TG; Zhang A; Coba M; Grunseich C; Ward ME; van den Berg LH; Pasterkamp RJ; Trotti D; Zlokovic BV; Ichida JK
    Nat Med; 2018 Mar; 24(3):313-325. PubMed ID: 29400714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.